Skip to main content
Clinical Trials/NCT03594084
NCT03594084UnknownNot Applicable

Retrospective Clinical Study of Malaria in Strasbourg University

University Hospital, Strasbourg, France1 site in 1 country70 target enrollmentStarted: August 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.

Study Overview

Brief Summary

The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
1 Day to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient over 18 years
  • Patients from birth to 18 years
  • Patient submitted to guardianship
  • Patient submitted to trusteeship
  • Diagnosis patients with malaria from 01/01/2017 to 01/01/2018
  • Patient or legal representative agree to use medical data for this research

Exclusion Criteria

  • Lack of confirmation malaria diagnosis
  • Impossibility to inform patients
  • Patient who does not wish to participate in the study
  • Patient submitted to justice safeguarding

Outcomes

Primary Outcomes

Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.

Time Frame: The period from January 1st, 2017 to January 1st, 2018 will be examined

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials